Business
Trifork Labs company Dawn Health welcomes Cipio Partners to fuel the next phase of growth for AI-driven commercial and clinical companion applications
Trifork Labs company Dawn Health welcomes Cipio Partners to fuel the next phase of growth for AI-driven commercial and clinical companion applications Press releaseCopenhagen — February 10, 2026 — Dawn Health, a global leader in digital health co-founded by Trifork, today announced the completion of a €21.5 million growth investment round, following a new investment from Cipio Partners, joining the existing owner group alongside Chr. Augustinus Fabrikker (CAF), the Export and Investment Fund of
About this update from Trifork Group Ag
[{"type":"image","alt":"Trifork Group AG","displaySize":"","headline":null,"caption":"Trifork Group AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":33,"url":"https://media.zenfs.com/en/globenewswire.com/c1ccd96164d39eab5be12ac9e3d1837d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_3T2cd7JZbys38Aozvbluw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQ2O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/c1ccd96164d39eab5be12ac9e3d1837d","width":300,"height":33}},"lazy":false},{"type":"text","content":"Trifork Labs company Dawn Health welcomes Cipio Partners to fuel the next phase of growth for AI-driven commercial and clinical companion applications","length":150,"tagName":"p"},{"type":"text","content":"Press releaseCopenhagen — February 10, 2026 — Dawn Health, a global leader in digital health co-founded by Trifork, today announced the completion of a €21.5 million growth investment round, following a new investment from Cipio Partners, joining the existing owner group alongside Chr. Augustinus Fabrikker (CAF), the Export and Investment Fund of Denmark (EIFO), and Trifork. The investment builds on the growth funding provided by the company’s existing owners and will support Dawn Health’s continued expansion as an AI-enabled patient companion partner for pharma across clinical, medical, and commercial activities.","length":623,"tagName":"p"},{"type":"text","content":"Over the past years, Dawn Health has built a trusted platform and ecosystem supporting the world's leading pharma companies in driving value across use cases spanning the clinical to commercial continuum. As the platform is widely adopted by pharma as well as leading technology and AI partners, the investment will further accelerate product innovation and continued value creation for these partners.","length":406,"tagName":"p"},{"type":"text","content":"Cipio Partners brings extensive experience in scaling global B2B technology companies and sees Dawn Health uniquely positioned to become a long-term category leader in regulated digital health.","length":193,"tagName":"p"},{"type":"text","content":"“We are very excited to welcome Cipio Partners as an investor,” said Alexander Mandix Hansen, CEO of Dawn Health. “We see a strong alignment between Cipio’s capabilities and ambitions and the strategy of our company, as well as the vision of our existing...